These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16338251

  • 1. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 7. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A, Andrikopoulos G, Lekakis J, Kalantzi K, Kitsiou A, Toli K, Floros D, Gaita D, Karalis I, Dragomanovits S, Kalogeropoulos P, Synetos A, Koutsogiannis N, Stougiannos P, Antonakoudis C, Goudevenos J, HELIOS group.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [Abstract] [Full Text] [Related]

  • 8. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Influence of percutaneous coronary intervention in non ST-elevation acute coronary syndromes on prescription of secondary prevention medications. Data from the S-Témoin Registry].
    Danchin N, Thébaut JF, Diévart F, Grenier O, Mihci E, Herrmann MA, Ferrières J.
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):30-5. PubMed ID: 17343036
    [Abstract] [Full Text] [Related]

  • 11. Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study.
    Gitt AK, Schiele R, Wienbergen H, Zeymer U, Schneider S, Gottwik MG, Senges J, MITRA Study.
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S343-7. PubMed ID: 14704866
    [Abstract] [Full Text] [Related]

  • 12. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A, Fonarow GC, Eagle KA, Hirsch AT, Califf RM, Alberts MJ, Boden WE, Steg PG, Shao M, Bhatt DL, Cannon CP, REACH Investigators.
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [Abstract] [Full Text] [Related]

  • 13. An intervention to improve secondary prevention of coronary heart disease.
    Bailey TC, Noirot LA, Blickensderfer A, Rachmiel E, Schaiff R, Kessels A, Braverman A, Goldberg A, Waterman B, Dunagan WC.
    Arch Intern Med; 2007 Mar 26; 167(6):586-90. PubMed ID: 17389290
    [Abstract] [Full Text] [Related]

  • 14. Patients undergoing coronary revascularisation: a missed opportunity for secondary prevention?
    Fox DJ, Kibiro M, Eichhöfer J, Curzen NP.
    Postgrad Med J; 2005 Jun 26; 81(956):401-3. PubMed ID: 15937208
    [Abstract] [Full Text] [Related]

  • 15. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 26; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics.
    Cambou JP, Simon T, Mulak G, Bataille V, Danchin N.
    Arch Mal Coeur Vaiss; 2007 Mar 26; 100(6-7):524-34. PubMed ID: 17893635
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U, Lindbäck J, Wallentin L, RIKS-HIA Registry.
    Circulation; 2005 Nov 22; 112(21):3225-31. PubMed ID: 16301355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.